The closest photo above is Stephen Goldman, Here is his bio and info:
Stephen Goldman is an analytical chemist with extensive industrial and academic laboratory experience. He currently serves as the Laboratory Director at PhytaTech. His expertise includes methodology (GC, HPLC and mass spectrometry), chemical and biochemical engineering, as well as project and business management. Prior to joining PhytaTech, Stephen served as an analytical chemist at the CLIA and CAP certified Forensic Laboratories, specializing in toxicology testing. Earlier, he was a scientist-chemist for Novartis (Sandoz), Kemin Industries, Genentech and served as a contract chemist. In that capacity, Stephen was involved in research into biocatalyst production and new chemistry products, neutraceuticals, antibody conjugate linkers, technical services, quality control, analytical method development and validation.
Before embarking on a career in the private sector, he was a research assistant in academic laboratories at the University of Kansas and the University of Iowa. There, he engaged in research into the intracellular trafficking, cellular localization and stability of small molecules as well as the purification and quantification of heparin oligosaccharides. Stephen has published a number of research papers in the fields of biological and analytical chemistry. He is a member of the American Institute of Chemical Engineers, American Association of Pharmaceutical Scientists and the American Chemical Society. Stephen has a Master of Science in Pharmaceutical Chemistry with Honors from the University of Kansas and a Bachelor of Science in Chemical and Biochemical Engineering from the University of Iowa.
Please edit as needed as it is a bit long. I see the equipment issue is done so I’ll think about what I’d like to get into the methodologies issue coming up in June. When is the deadline?